There was an increasing trend of the proportion of CRF55_01B samples, rising from 2.3% in 2015 to 3.9% in 2018 and 4.1% in 2022 in China [ 34 ].
← all excerpts
Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study.
1
—
—